TB / MDR TB Project

TB / MDR TB Project

World Economic Forum (WEF)

Health is one of the World Economic Forum's key focus areas as it is directly aligned with the Forum's mission: Committed to improving the state of the world by engaging leaders in shaping the global, regional and industry agendas. The Forum focuses on three key health-related activities: advocacy, dialogue and action through partnership.

The Forum recognises health as an important part of long-term economic development and engages its members and other stakeholders to advocate health as an investment.

Vendredi, 04 Juin 2010 07:49

2010 TB Award Recipients

Twelve Nurses win the 4th ICN/Lilly Award  for Work in Tuberculosis and Multi-drug Resistant TB

The ICN/Lilly Award for Nursing Excellence in TB/MDR-TB is one aspect of ICN’s work in TB and multi-drug resistant TB as a founding member of the Lilly MDR-TB Partnership. Through this Partnership more than 18 000 nurses have been trained in TB endemic countries. This annual award supported by Lilly recognizes nursing expertise and aims to motivate and recognise nurses working with those affected by TB and MDR-TB in countries included in the TB project. It showcases the contribution made by nurses to TB prevention, care and treatment and offers the recipients an educational grant to continue their professional development along with a specially designed medal. Recipients are selected by their national nurses association for their outstanding achievement in TB prevention, care and treatment.

On the occasion of World TB Day, the International Council of Nurses in partnership with Eli Lilly and Company has given awards to the following nurses, from eleven countries, who through their dedication, passion and innovative care strategies, are living examples of the World TB Day slogan "On the move against tuberculosis: innovate to accelerate action".

World Health Organisation (WHO)

The WHO Global TB Programme aims to advance universal access to TB prevention, care and control, guide the global response to threats, and promote innovation.

Core functions

  • Provide global leadership on matters critical to TB;
  • Develop evidence-based policies, strategies and standards for TB prevention, care and control, and monitor their implementation;
  • Jointly with WHO regional and country offices, provide technical support to Member States, catalyze change, and build sustainable capacity;
  • Monitor the global TB situation, and measure progress in TB care, control, and financing;
  • Shape the TB research agenda and stimulate the generation, translation and dissemination of valuable knowledge;
  • Facilitate and engage in partnerships for TB action.


Lundi, 08 Mars 2010 13:29

2009 TB Award Recipients

Eleven Nurses win the 3rd ICN/Lilly Award for Work in Tuberculosis and Multi-drug Resistant TB

On the occasion of World TB Day, the International Council of Nurses (ICN), in partnership with Eli Lilly and Company, conferred special awards to the following nurses who have demonstrated exceptional dedication to the fight against the scourge of tuberculosis (TB) in their countries.

World Medical Association (WMA)

The World Medical Association (WMA) is an international organization representing physicians. It was founded on 17 September 1947, when physicians from 27 different countries met at the First General Assembly of the WMA in Paris. The organization was created to ensure the independence of physicians, and to work for the highest possible standards of ethical behaviour and care by physicians, at all times. This was particularly important to physicians after the Second World War, and therefore the WMA has always been an independent confederation of free professional associations. Funding has been by the annual contributions of its members, which has now grown to 100 National Medical Associations.

The WMA provides a forum for its member associations to communicate freely, to co-operate actively, to achieve consensus on high standards of medical ethics and professional competence, and to promote the professional freedom of physicians worldwide.

This unique partnership facilitates high-calibre, humane care to patients in a healthy environment, enhancing the quality of life for all people in the world.

Lundi, 08 Mars 2010 13:34

2008 TB Award Recipients

Eleven Nurses Win the 2nd ICN/Lilly  Award for Work in Tuberculosis and Multi–drug Resistant TB

On the occasion of World TB Day, the International Council of Nurses (ICN), in partnership with Eli Lilly and Company, conferred special awards to nurses working on the ground in fighting the scourge of tuberculosis (TB) and multi-drug resistant TB. The 2008 award recipients come from six TB affected countries: Kenya, Lesotho, Malawi, the Russian Federation, South Africa and Swaziland.

Lundi, 08 Mars 2010 13:35

2007 TB Award Recipients

Five Nurses Win the Newly Launched ICN/Lilly Award for Work in Tuberculosis and Multi–drug Resistant TB.

Mercredi, 08 Avril 2015 14:49

Training for the Fight Against TB

This article was written by Carrie Tudor, TB Project Director, and published in
the “HIV Nursing matters” journal, a publication of the Southern African HIV Clinicians Society.

Please click here to read the article


Vendredi, 09 Octobre 2015 16:55

Partners in Development Award

We are pleased to inform you that our sponsor, Eli Lilly and Company, is the recipient of the 2015 ICN Partners in Development Award.

Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation, has worked with ICN since 2003 to strengthen the global nursing capacity in the prevention, detection, care and treatment of TB and M/XDR-TB in countries with high burdens.

The ICN-Lilly TB/MDR-TB project has reached more than 90,000 nurses and allied health workers in China, Colombia, Egypt, Ethiopia, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, Philippines, Russia, Senegal, South Africa, Swaziland, Togo, Uganda, and Zambia. In the most recent phase, activity has focused on four core countries – China, India, Russia and South Africa.

to learn more click here 

TB Online Learning Resources

ICN has developed an exciting new on-line course on the Care, prevention and management of tuberculosis (TB) which provides practical tools to nurses and those working with patients, families and communities affected by TB, including drug-resistant TB. The course is widely applicable for all settings, while also dealing with the challenges of providing care when resources are scarce and the workload is high. 

The course is broken down into a series of standards each addressing an important part of the patient's journey from before diagnosis to the end treatment. Each standard considers the resources, professional practice and knowledge required to meet the standard as well as how to measure progress. In addition to gaining practical knowledge through a variety of interactive exercises, there are opportunities to reflect on your own services and plan improvements.  

Standard statement: A good relationship is developed with the patient while symptoms, signs and risk factors consistent with TB are assessed and investigated appropriately

Sputum Testing

Standard statement:The patient produces good quality sputum specimens, delivers them to the appropriate place at the appropriate time and returns for the results. 

Standard statement: Each patient is registered appropriately, started on an approved treatment regimen and given practical advice, support and information according to their individual needs and concerns.
Standard statement: DOT will be arranged in the most convenient and reliable way possible taking into account the patient’s needs and wishes as well as local resources.
Standard statement: Contact tracing and investigation is carried out according to locally agreed protocols
Standard statement: Patient progress and DOT arrangements are monitored according to a schedule agreed upon between the Unit Coordinator, all health-care workers and other individuals designated to be involved in the care of TB patients.
Standard statement: Patients who do not attend when expected will be followed up, assessed and enabled to resume treatment as soon as possible.
Standard statement: Patients are assessed at the end of their intensive phase of treatment and a plan is developed with the patient for the continuation phase during which they are likely to have less contact with the management unit.
Case Management in the Continuation Phase
Standard statement: Ongoing support is available according to patient need and the necessary follow-up investigations are carried out.
Standard statement: Treatment is continuous throughout the course and appropriate arrangements are made if the patient needs to transfer his or her care to another management unit
Standard statement: Diagnostic HIV testing will be offered routinely to all patients with TB who do not know their HIV status, in a caring, consensual and confidential manner
Standard statement: The patient receives prophylactic treatment against common opportunistic infections, support and information with regard to staying healthy with HIV, including treatment with antiretroviral drugs, if appropriate, while on TB treatment before being transferred for ongoing care.



Page 6 sur 20